Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bio Preventive Medicine Corp (6810) Fair Value & Analysis

Healthcare · TW · Market cap 1.4B TWD

Price25.50 TWD
Fair Value18.64 TWD
Upside-26.9%
Quality95/100
Evidence: Low Range 13.98 TWD – 23.30 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Bio Preventive Medicine Corp (6810) currently trades at 25.50 TWD, while our model-based Fair Value estimate is 18.64 TWD — implying the stock looks roughly 26.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Bio Preventive Medicine Corp., a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It also provides DNlite test, a series of patented and clinically validated non-invasive urine test for monitoring the progression of diabetic nephropathy, including DNlite-IVD103 and DNlite-DN_Score. Bio Preventive Medicine Corp. was founded in 2014 and is headquartered in Zhubei, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Bio Preventive Medicine Corp (6810) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 18.64 TWD versus a price of 25.50 TWD — about −27% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6810?
Our 21-model fair value for Bio Preventive Medicine Corp is 18.64 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 25.50 TWD.
What is the quality score of 6810?
Bio Preventive Medicine Corp has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.